Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab
Clinical trial NCT01544595 · COMPLETED
Trial details
- NCT number
- NCT01544595
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-19
- Primary completion
- 2017-06-26
- Enrollment
- 1147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.